Animal studies confirm that blockade of RAGE or HMGB1 signaling significantly reduces collagen deposition and inflammation in lung tissue, highlighting this pathway as a potential therapeutic target for pulmonary fibrosis. This evidence concerns the gene AGER and pulmonary fibrosis.